Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 05, 2026 07:01 ET | Source: Invivyd NEW HAVEN, Conn., May…
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 01, 2026 17:30 ET | Source: ZENTALIS PHARMACEUTICALS SAN DIEGO, May…
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 24, 2026 08:00 ET | Source: Aligos Therapeutics SOUTH SAN FRANCISCO,…
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
April 03, 2026 16:01 ET | Source: Syndax Pharmaceuticals, Inc. NEW YORK,…
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 03, 2026 16:00 ET | Source: IN8bio, Inc NEW YORK, April…
Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)
March 20, 2026 16:30 ET | Source: Zevra Therapeutics BOSTON, March 20,…
Crescent Biopharma Announces Grants of Inducement Awards
March 06, 2026 16:15 ET | Source: Crescent Biopharma, Inc. WALTHAM, Mass.,…
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRINCETON, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq:…
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 06, 2026 17:33 ET | Source: Tango Therapeutics Sub, Inc BOSTON,…
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq:…
